The lines between medical machine qualification and validation are frequently blurred. Despite its dizzying complexity with countless integral pieces that need to slot into place, it’s a high stake process that’s reliant on input from numerous industry stakeholders. Yet, this risks over specifying manufacturing aberrations, often leading to nonsensical decisions that retrospectively should never have been documented in the first place during the machine design phase. At some point pragmatism has to step forward and override bureaucracy.
Medical Business Development Director at Sumitomo (SHI) Demag Anatol Sattel assembles the company’s very best qualification and validation experts, including Medical Sales Director Andrew Sargisson, Project Manager Erik Schalle, and UK medical sales specialist Sam Carr to reassure and describe how their teams work collaboratively with medical customers to support the entire Validation process.